<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) but without previously known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have a high prevalence of undiagnosed IGT and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Such perturbations have dismal prognostic implications </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to characterise <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> patients in terms of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and beta cell function </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A total of 168 consecutive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> patients were classified by means of an OGTT before hospital discharge as having NGT, IGT or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The homeostasis model assessment (HOMA-IR) was used to estimate <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Beta cell responsiveness was quantified as insulinogenic index (IGI) at 30 min (DeltaI(30)/DeltaG(30)) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: According to the HOMA-IR, patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were more insulin resistant than those with IGT or NGT (p=0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>Beta cell responsiveness deteriorated with decreasing <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance as measured by the IGI (median [quartile 1, quartile 3] in pmol/mmol: NGT, 70.1 [42.7, 101.4]; IGT, 48.7 [34.7, 86.8], type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 38.1 [25.7, 61.6]; p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>The IGI was significantly related to admission capillary blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (r=-0.218, p=0.010) and to the area under the curve for <z:chebi fb="105" ids="17234">glucose</z:chebi> (r=-0.475, p&lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:chebi fb="105" ids="17234">Glucose</z:chebi> abnormalities are very common in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> but without previously known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>To a significant extent, this seems to be related to impaired beta cell function and implies that dysglycaemia immediately after an infarction is not a stress epiphenomenon but reflects stable disturbances of <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation preceding the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Early <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> may have important pathophysiological implications and may serve as a future target for treatment strategies </plain></SENT>
</text></document>